We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
-8.41%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$22.8B
AUM Growth
-$4.41B
(-16%)
Cap. Flow
-$1.27B
Cap. Flow
% of AUM
-5.6%
Top 10 Holdings %
Top 10 Hldgs %
36.84%
Holding
614
New
135
Increased
158
Reduced
239
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$187M |
| 3 |
Netflix
NFLX
|
+$179M |
| 4 |
Starbucks
SBUX
|
+$114M |
| 5 |
Novartis
NVS
|
+$92.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$260M |
| 2 |
Microsoft
MSFT
|
+$208M |
| 3 |
Salesforce
CRM
|
+$171M |
| 4 |
Dollar Tree
DLTR
|
+$171M |
| 5 |
Adobe
ADBE
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.16% |
| 2 | Healthcare | 22.78% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Communication Services | 9.78% |
| 5 | Financials | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBIS
251
Nebius Group N.V.
NBIS
$48.3B
| $2.63M | 0.01% |
77,205
-56,180
| -42% | -$2.32M |
|
252
Blackrock
BLK
$169B
| $2.62M | 0.01% |
5,950
-136
| -2% | -$67K |
|
253
CVS Health
CVS
$133B
| $2.61M | 0.01% |
43,953
-9,311
| -17% | -$622K |
|
254
Rockwell Automation
ROK
$53.4B
| $2.55M | 0.01% |
16,927
-141,117
| -89% | -$26.2M |
|
255
Roper Technologies
ROP
$38.8B
| $2.54M | 0.01% |
8,129
-4,487
| -36% | -$1.59M |
|
|
GRMN
256
Garmin
GRMN
$56.7B
| $2.51M | 0.01% |
33,461
-22,172
| -40% | -$2.01M |
|
257
Cisco
CSCO
$457B
| $2.47M | 0.01% |
62,768
-3,957
| -6% | -$174K |
|
258
nLIGHT
LASR
$3.88B
| $2.44M | 0.01% |
232,485
-58,475
| -20% | -$997K |
|
|
TPTX
259
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $2.37M | 0.01% |
53,112
-7,026
| -12% | -$373K |
|
|
ZUO
260
DELISTED
Zuora, Inc.
ZUO
| $2.34M | 0.01% |
290,685
-6,015
| -2% | -$79.1K |
|
261
ResMed
RMD
$30.6B
| $2.34M | 0.01% |
+15,881
| New | +$2.53M |
|
262
10x Genomics
TXG
$6B
| $2.27M | 0.01% |
36,417
+1,714
| +5% | +$134K |
|
263
Baxter International
BAX
$13.5B
| $2.19M | 0.01% |
+27,000
| New | +$2.33M |
|
264
WisdomTree
WT
$2.96B
| $2.17M | 0.01% |
929,183
-8,488,016
| -90% | -$32.9M |
|
265
Broadcom
AVGO
$1.85T
| $2.15M | 0.01% |
90,600
-1,089,390
| -92% | -$30.7M |
|
266
Pool Corp
POOL
$6.75B
| $2.14M | 0.01% |
10,859
+10,462
| +2,635% | +$2.23M |
|
267
Affiliated Managers Group
AMG
$9.69B
| $2.04M | 0.01% |
+34,432
| New | +$2.58M |
|
268
LivePerson
LPSN
$21.8M
| $2.03M | 0.01% |
5,956
+4,774
| +404% | +$2.31M |
|
|
BBBY
269
DELISTED
Bed Bath & Beyond Inc
BBBY
| $2.03M | 0.01% |
481,535
-130,578
| -21% | -$1.52M |
|
270
Carlyle Group
CG
$16.6B
| $2.02M | 0.01% |
+93,454
| New | +$2.7M |
|
271
Edwards Lifesciences
EW
$49.6B
| $2.02M | 0.01% |
32,157
-3,207
| -9% | -$231K |
|
272
Phreesia
PHR
$663M
| $2.02M | 0.01% |
95,922
-44,408
| -32% | -$1.22M |
|
|
RETA
273
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.98M | 0.01% |
13,742
+5,242
| +62% | +$1.01M |
|
274
Magnolia Oil & Gas
MGY
$6.09B
| $1.98M | 0.01% |
494,697
+102,907
| +26% | +$886K |
|
|
KL
275
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $1.98M | 0.01% |
+66,800
| New | +$2.44M |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q1 2020 Portfolio in Review
As of Q1 2020, Fred Alger Management held 614 positions worth $22.8B, down 16% from $27.2B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Fred Alger Management withdrew a net $1.27B in Q1 2020, closing 65 positions and reducing 239 holdings. Its most notable exit was Dermira, Inc., an estimated $46.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in AtriCure worth $42.4M.
- Fred Alger Management's largest Q1 2020 buy was AtriCure: 1,263,408 shares worth $42.4M.
- Fred Alger Management added most to NVIDIA in Q1 2020, an estimated $190M increase.
- Fred Alger Management's biggest Q1 2020 reduction was Abbott, cutting an estimated $260M.
- Fred Alger Management fully exited Dermira, Inc. in Q1 2020, selling an estimated $46.3M.
- Fred Alger Management's ten largest holdings make up 37% of its $22.8B portfolio in Q1 2020.
- Fred Alger Management opened 135 new positions and closed 65 in Q1 2020.
- Fred Alger Management's portfolio value fell 16% quarter-over-quarter to $22.8B.
Based on Fred Alger Management's 13F filing for Q1 2020, filed 15 May 2020.